Heterozygosity for Tay-Sachs and Sandhoff diseases among Massachusetts residents with French Canadian background

Journal of Medical Screening

Volumn 4, Issue 3, 1997, Pages 133-136

  Prence, Elizabeth M ^a   Jerome, Cheryl A ^b   Triggs Raine, Barbara L ^b   Natowicz, Marvin R ^a,c,d  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MANITOBA   (Canada)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

French Canadians; Sandhoff disease; Tay Sachs disease

Indexed keywords

BETA N ACETYLHEXOSAMINIDASE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE MUTATION; GENETIC RISK; GENETIC SCREENING; HETEROZYGOSITY; HETEROZYGOTE DETECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; SANDHOFF DISEASE; TAY SACHS DISEASE;

EID: 0031395672     PISSN: 09691413     EISSN: None     Source Type: Journal    
DOI: 10.1177/096914139700400304     Document Type: Article

References (24)

1. M2 gangliosidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease. 7th ed. New York: McGraw-Hill, 1995: 2839-79.
2. Natowicz MR, Prence EM. Heterozygote screening for Tay-Sachs disease: past successes and future challenges. Current Opin Pediatr 1996;8:625-9.
3. Conzelmann E, Sandhoff K. Partial enzyme deficiencies: residual activities and the development of neurological disorders. Dev Neurosci 1983/84;6:58-71.
4. Leinekugel P, Michel S, Conzelmann E, Sandhoff K. Quantitative correlation between the residual activity of beta-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease. Hum Genet 1992;88:513-23.
5. Kaback M, Lim-Steele J, Dabholkar D, Brown D, Levy N, Zeiger K. Tay-Sachs disease-carrier screening, prenatal diagnosis, and the molecular era. JAMA 1993;270:2307-15.
6. Triggs-Raine BL, Mules EH, Kaback MM, et al. A pseudo-deficiency allele common in non-Jewish Tay-Sachs carriers: implications for carrier screening. Am J Hum Genet 1992;51:793-801.
7. Cao Z, Natowicz MR, Kaback MM, et al. A second mutation associated with apparent beta-hexosaminidase A pseudodeficiency: identification and frequency estimation. Am J Hum Genet 1993;53:1198-205.
8. Peterson GM, Rotter JI, Cantor RM, et al. The Tay-Sachs disease gene in Northern American Jewish populations: geographic variations and origin. Am J Hum Genet 1983;35:1258-69.
9. Andermann E, Scriver CR, Wolfe LS, Dansky L, Andermann F. Genetic variants of Tay-Sachs disease: Tay-Sachs disease and Sandhoff's disease in French-Canadians, juvenile Tay-Sachs disease in Lebanese Canadians and a Tay-Sachs screening program in the French Canadian population. In: Kaback MM, ed. Tay-Sachs disease: screening and prevention. New York: Alan R Liss, 1977: 161-88.
10. van Bael M, Natowicz MR, Tomczak J, Grebner EE, Prence EM. Heterozygosity for Tay-Sachs disease in non-Jewish Americans with ancestry from Ireland or Great Britain. J Med Genet 1996;33:829-32.
11. Triggs-Raine BL, Feigenbaum ASJ, Natowicz M, et al. Screening for carriers of Tay-Sachs disease among Ashkenazi Jews. N Engl J Med 1990;323:6-12.
12. Myerowitz R, Hogikyan ND. Different mutations in Ashkenazi Jewish and non-Jewish French Canadians with Tay-Sachs disease. Science 1986;232:1646-8.
13. Hechtman P, Kaplan F, Bayleran J, et al. More than one mutant allele causes infantile Tay-Sachs disease in French Canadians. Am J Hum Genet 1990;47:815-22.
14. Brault G. The French Canadian Heritage in New England. Kingston, Ontario: University Press of New England/ McGill-Queens University Press, 1986.
15. Kanzler EM. Processes of immigration: the Franco Americans of Manchester, New Hampshire, 1875-1925. Illinois StateUniversity. [Dissertation]. Ann Arbor: University Microfilms International, 1982.
16. Triggs-Raine B, Richard M, Wasel N, Prence EM, Natowicz MR. Mutational analyses of Tay-Sachs disease: studies on Tay-Sachs carriers of French Canadian background living in New England. Am J Hum Genet 1995;56:870-9.
17. Natowicz MR, Prence EM, Cajolet A. Marked variation in blood beta-hexosaminidase in Gaucher disease. Clin Chim Acta 1991;203:17-22.
18. Prence EM, Natowicz MR, Zalewslu I. Unusual thermolability properties of leukocyte beta-hexosaminidase: implications in screening for carriers of Tay-Sachs disease. Clin Chem 1993;39:1811-4.
19. Akli S, Chelly J, Lacorte J-M, Poenaru L, Kahn A. Seven novel Tay-Sachs mutations detected by chemical mismatch cleavage of PCR-amplified cDNA fragments. Genomics 1991;11:124-34.
20. Fernandes M, Kaplan F, Natowicz M, et al. A new Tay-Sachs disease B1 allele in exon 7 in two compound heterozygotes each with a second novel mutation. Hum Mol Genet 1992;1:759-61.
21. Myerowitz R, Costigan FC. The major defect in Ashkenazi Jews with Tay-Sachs disease is an insertion in the gene for the alpha chain of beta-hexosaminidase. J Biol Chem 1988; 263: 18587-9.
22. Dominic VR. Immigration of French Canadians to New England, 1840-1900: a geographical analysis. University of Wisconsin. [Dissertation]. Ann Arbor: University Microfilms International, 1968.
23. Palomaki GE, Williams J, Haddow JE, Natowicz MR. Tay-Sachs disease in persons of French-Canadian heritage in northern New England. Am J Med Genet 1995;56:409-12.
24. Natowicz MR, Alper JS. Genetic screening: triumphs, problems, and controversies. J Pub Health Policy 1997;12:475-91.